Skip to main content

Result releasedAnnolyse analysis published

Cash conversion collapsed to 15.4% as working capital absorbed $348m

Revenue grew 13.0% and FY26 EBITDA guidance was reaffirmed, but operating cash flow fell to $46.6m and the dividend was not covered by free cash flow.

EBO revenue trajectory

Revenue context before the current result.

Loading chart...
HY26 was $6.8b, versus $6b in HY25.

EBO EBITDA margin

EBITDA margin across covered periods.

Loading chart...
HY26 was 4.5%, versus 4.6% in HY25.

EBO operating cash flow

Operating cash flow across covered periods.

Loading chart...
HY26 was $46.6m, versus $189.8m in HY25.

EBO NPAT trajectory

Statutory profit after tax across covered periods.

Loading chart...
HY26 was $124.8m, versus $110.5m in HY25.

Market context

Valuation

These ratios pair a market close from around the result date with verified filing data. An unavailable metric means the required inputs were missing or unsuitable for comparison.

Prices as at close, 2 September 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$4.3b

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

19.07x

i

Recent market cap compared with trailing earnings.

EPS

1.09

i

Recent filing-derived earnings per share.

PEG

4.06x

i

P/E compared with recent earnings growth.

EV/EBITDA

8.9x

i

Enterprise value compared with recent EBITDA.

P/FCF

21.06x

i

Market cap compared with recent free cash flow.

P/B

1.59x

i

Market value compared with latest reported equity.

Income and investment-company measures

Yield and investment-company valuation where supported.

Dividend yield

5.7%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
25 February 2026
Published
21 April 2026

Key metrics

Numbers worth scanning first

HY26 vs HY25

Revenue

$6.8b

Caveat: metric quality flags apply; use this value with basis context.

EBITDA

$302.7m

Caveat: metric quality flags apply; use this value with basis context.

Net profit after tax

$124.8m

Caveat: metric quality flags apply; use this value with basis context.

Net cash inflow from operating activities

$46.6m

Caveat: metric quality flags apply; use this value with basis context.

Interim dividend per share

57.0c

flat vs 57.0c

Total assets

$7.6b

Caveat: metric quality flags apply; use this value with basis context.

Analysis ofEBO HY26Result releasedAnnolyse analysis published

What changed

Operating cash flow fell to $46.6m from $189.8m in HY25, a 75.5% decline that pulled cash conversion (OCF/EBITDA) down to 15.4% from 68.8%

Free cash flow was negative $24.0m, while working capital absorbed roughly $348m, with trade debtors up 17.3% to $1.7b against revenue growth of 13.0%.

Revenue rose 13.0% to $6.8b and reported EBITDA rose 9.7% to $302.7m. Profit before tax grew 4.4% to $162.7m, while NPAT grew 12.9% to $124.8m, lifted by a fall in the effective tax rate to 22.2% from 28.3%. The interim dividend was held at 57.0 cps.

Gross borrowings rose to $1.4b and net debt to $1.1b, but net debt/EBITDA edged down to 3.7x from 3.9x on the trailing earnings base.

What matters

The headline NPAT is tax-flattered; PBT is the cleaner read

Payout ratio versus pre-lease FCF is suppressed because the source-backed cash-dividend bridge is unavailable.

PBT grew 4.4% while NPAT grew 12.9%, an 8.5 percentage-point gap driven by the effective tax rate dropping 6.1pp. Operating earnings are growing well below the rate the bottom line implies, and the 4.4% PBT growth sits well below the 13.0% revenue line.

Working capital is the swing factor. Receivable days rose to 45.0 from 43.3 and operating working capital expanded by around $348m, more than the entire prior-year half's OCF. Unless this unwinds in H2, leverage discipline and dividend cover both depend on it.

Expectations

Management has reaffirmed FY26 EBITDA guidance and signalled confidence in an H2 uplift driven by productivity and utilisation of strategic investments

The supplied seasonal pattern shows HY25 delivered 48.8% of FY25 revenue, 49.6% of EBITDA and 51.4% of NPAT, and operating cash flow was historically more H2-weighted (HY25 represented 45.4% of FY25 OCF). That shape is consistent with management's H2 framing on earnings, but it does not by itself rescue the cash gap.

Underlying EBITDA was disclosed at $300m, up 3.2% — well below the 9.7% reported EBITDA growth — which sets a more modest organic baseline against which the reaffirmed guidance and "H2 uplift" claim should be judged.

Quality of result

The result is lower quality than the headlines suggest

NPAT growth of 12.9% reflects a step-down in the effective tax rate to 22.2%, not operating leverage; on the cleaner PBT basis growth was 4.4%, less than a third of revenue growth. Reported EBITDA grew 9.7% but Underlying EBITDA grew only 3.2%, indicating non-underlying items are a meaningful contributor to the reported growth rate.

On the cash side, capex rose 26.7% to $70.6m (1.0% of revenue), but the dominant pressure was working capital. With OCF of $46.6m against EBITDA of $302.7m, around $256m of EBITDA did not arrive as operating cash this half. Whether this is timing-driven (debtor build into period-end, seasonal stocking) or a structural step-up in working capital intensity is the central durability question for the result.

Unresolved

Open questions

What specifically drove the $348m working capital absorption, and how much is expected to reverse in H2 FY26?
Why did the effective tax rate fall to 22.2% from 28.3%, and is this a sustainable run-rate?
Why does Underlying EBITDA growth of 3.2% diverge so sharply from reported EBITDA growth of 9.7%?
How is the maintained 57.0 cps interim dividend being funded given FCF of -$24.0m, and what is the policy if cash conversion does not normalise?
What concrete productivity and utilisation milestones underpin the reaffirmed FY26 EBITDA guidance and the H2 uplift confidence?

This briefing cannot assess customer-level receivables ageing, the split of the working capital build between volume, mix and timing, or any segment-level cash conversion behind the group OCF figure.

Ask about EBO HY26

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about EBOS Group's HY26 result.

What specifically drove the $348m working capital absorption, and how much is expected to reverse in H2 FY26?Why does "The headline NPAT is tax-flattered; PBT is the cleaner read" matter?How strong was the cash and earnings quality in HY26?What should I watch next for EBO after HY26?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Prior comparable period

Full-year context

Release context

Annual Meeting Presentations

HY26 / commentary

Get notified when EBO publishes next

Get the next EBOS Group briefing and related NZX reporting-season updates by email.